Genscript Biotech Co. (OTCMKTS:GNNSF) Short Interest Down 70.6% in February

Genscript Biotech Co. (OTCMKTS:GNNSF) was the recipient of a large decline in short interest in February. As of February 15th, there was short interest totalling 549,600 shares, a decline of 70.6% from the January 31st total of 1,867,800 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is currently 2,748.0 days.

Genscript Biotech Price Performance

OTCMKTS GNNSF remained flat at C$1.90 during mid-day trading on Friday. Genscript Biotech has a twelve month low of C$1.05 and a twelve month high of C$2.05. The company has a 50 day moving average price of C$1.40 and a 200-day moving average price of C$1.41.

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.